A dosing regimen for immediate N-acetylcysteine treatment for acute paracetamol overdose

References

• Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol (acetaminophen) poisoning. BMJ 1979; 2:1097–1100.
   PubMed Web of Science ®Google Scholar
• Koch-Weser J. Acetaminophen. N Engl J Med 1976; 295: 1297–1300.
   PubMed Web of Science ®Google Scholar
• Heard K. Acetylcysteine for acetaminophen poisoning. New Engl J Med 2008; 359:285.
   PubMed Web of Science ®Google Scholar
• Gunnell D, Murray B, Hawton K. Use of paracetamol (acetaminophen) for suicide and nonfatal poisoning: worldwide patterns of use and misuse. Suicide Life Threat Behav 2000; 30:313–326.
   PubMed Web of Science ®Google Scholar
• Prescott LF, Roscoe P, Wright N, Brown SS. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971; 297:519–522.
   Google Scholar
• Brok J, Buckley N, Glund C. Interventions for paracetamol (acetaminophen) overdose. The Cochrane Library 2009(1).
   Google Scholar
• Jones AL. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. Clin Toxicol 1998; 36:277–285.
   Web of Science ®Google Scholar
• Daly FFS, Fountain JS, Murray L, Graudins A, Buckley N. Guidelines for the management of paracetamol poisoning in Australia and New Zealand – explanation and elaboration. Med J Aust 2008; 188:296–302.
   PubMed Web of Science ®Google Scholar
• Kerr F, Dawson A, Whyte IM, Buckley N, Murray L, Graudins A, Chan B, Trudinger B. The Australasian clinical toxicology investigators collaboration randomised trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med. 2005; 45:402–408.
   PubMed Web of Science ®Google Scholar
• Mant TGK, Tempowski JH, Volans GN, Talbot JCC. Adverse reactions to acetylcysteine and effects of overdose. BMJ 1984; 289:217–219.
   PubMed Web of Science ®Google Scholar
• Chan TYK, Critchley JAJH. Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning. Hum Exp Toxicol 1994; 13:542–544.
   PubMed Web of Science ®Google Scholar
• Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998; 31:710–715.
   PubMed Web of Science ®Google Scholar
• Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol 2009; 47:81–88.
   PubMed Web of Science ®Google Scholar
• Donovan JW, Gorayeb MJ, Kulig KW. Adverse reactions to slow infusion of intravenous N-acetylcysteine [abstract]. Vet Hum Toxicol 1990; 32:347.
   Google Scholar
• Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989; 37:501–516.
   PubMed Web of Science ®Google Scholar
• Kumar VVP, Oscarsson S, Friberg LE, Isbister GK, Hackett LP, Duffull SB. The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose. Clin Pharmacol Ther 2009; 86:403–410.
   PubMed Web of Science ®Google Scholar
• Little M, Murray L, McCoubrie D, Daly FS. A potentially fatal prescribing error in the treatment of paracetamol poisoning. Med J Aust 2005; 183:535–536.
   PubMed Web of Science ®Google Scholar
• Bailey B, Blais R, Letarte A. Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death. Ann Emerg Med. 2004; 44:401–406.
   PubMed Web of Science ®Google Scholar
• Brown M, Bjorksten A, Medved I, McKenna M. Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise. Eur J Clin Pharmacol 2004; 60:717–723.
   PubMed Web of Science ®Google Scholar
• Olsson B, Johansson M, Gabrielsson J, Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 1988; 34:77–82.
   PubMed Web of Science ®Google Scholar
• Ponampalam R, Tan HH, Ng KC, . Demographics of toxic exposures presenting to three public hospital emergency departments in Singapore 2001–2003. Int J Emerg Med 2009; 2:25–31.
   PubMedGoogle Scholar
• Thomas SHL, Bevan L, Bhattacharyya S, Bramble MG, Chew K, Connolly J, Dorani B, Han KH, Horner JE, Rodgers A, Sen B, Tesfayohannes B, Wynne H, Bateman DN. Presentation of poisoned patients to accident and emergency departments in the North of England. Hum Exp Toxicol 1996; 15:466–470.
   PubMed Web of Science ®Google Scholar
• Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2001; 51:87–91.
   PubMed Web of Science ®Google Scholar
• Hanna D, Griswold P, Leape LL, Bates DW. Communicating critical test results: safe practice recommendations. J Qual Patient Saf 2005; 31:68–80.
   PubMedGoogle Scholar
• Rumack BH, Peterson RG. Acetaminophen overdose: incidence, diagnosis, and management in 416 patients. Pediatrics 1978; 62:898–903.
   PubMed Web of Science ®Google Scholar
• Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995; 346:547–552.
   PubMed Web of Science ®Google Scholar
• Waring WS, Stephen AF, Robinson OD, Dow MA, Pettie JM. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol (Phila) 2008; 46:496–500.
   PubMed Web of Science ®Google Scholar
• Graudins A, Chiew A, Chan B. Overdose with modified-release paracetamol results in delayed and prolonged absorption of paracetamol. Intern Med J 2010; 4091:72–76.
   Google Scholar
• Bourdeaux C, Bewley J. Death from paracetamol overdose despite appropriate treatment with N-acetylcysteine. Emerg Med J 2007;24:e31.
   PubMed Web of Science ®Google Scholar
• Parker D, White JP, Routledge PA. Safety of late acetylcysteine treatment in paracetamol poisoning. Hum Exp Toxicol 1990; 9:25–27.
   PubMed Web of Science ®Google Scholar